Effects of Sacrosidase and Placebo in Subjects With Fructan Intolerance

Clinical trial NCT05703009 · COMPLETED

Trial details

NCT number: NCT05703009
Sponsor: QOL Medical, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Fructan Intolerance

Start date: 2023-06-05
Primary completion: 2024-01-22
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.